2161 — Jbm (Healthcare) Share Price
0.000.00%
Last trade - 00:00- HK$1.80bn
- HK$1.79bn
- HK$648.42m
- 89
- 66
- 79
- 93
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 9.7 | ||
| PEG Ratio (f) | 0.71 | ||
| EPS Growth (f) | 15.92% | ||
| Dividend Yield (f) | 4.42% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.82 | ||
| Price to Tang. Book | 10.15 | ||
| Price to Free Cashflow | 7.23 | ||
| Price to Sales | 2.55 | ||
| EV to EBITDA | 7.4 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 18.01% | ||
| Return on Equity | 16.27% | ||
| Operating Margin | 29.14% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | HK$m | 381.54 | 397.16 | 406.14 | 520.32 | 648.41 | 795.58 | 930.79 | 16.09% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -10.19 | -9.52 | -37.78 | +72.64 | +179.92 | +40.14 | +15.92 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
JBM (Healthcare) Ltd is an investment holding company principally engaged in the development, manufacture and distribution of Chinese medicines. The Company operates its business through three segments. The Branded Medicines segment is engaged in the development, manufacture and distribution of branded medicines with chemical compounds as active ingredients. The Proprietary Chinese Medicines segment is engaged in the development, manufacture and distribution of registered Chinese medicines composed solely of any Chinese herbal medicines specified in the Chinese Medicine Ordinance, or any materials of herbal, animal or mineral origin customarily or widely used by the Chinese. The Health and Wellness Products segment is engaged in the distribution and sale of supplements, medical consumables and other nonpharmaceutical products for the general health and wellness of consumers.
Directors
- Kwong Yip Sum NEC (58)
- Yat Wai Wong CEO (57)
- Man Yee Au COO (48)
- Ka Kin Wong VPR (47)
- Lin Wang DGM (55)
- Ka Wing Chu EDR (47)
- Kau Lap Lam OTH (34)
- Hoi Ki Leung OTH (38)
- Chui Yee Lo OTH (53)
- Kwok Chun Yeung NED (61)
- Chun Leung Yim NED (59)
- Kam Chiu Chan NID (72)
- Shut Lee Lau NID (52)
- Ting Lung Luk NID (59)
- Last Annual
- March 31st, 2024
- Last Interim
- September 30th, 2024
- Incorporated
- January 7th, 2020
- Public Since
- February 5th, 2021
- No. of Employees
- 279
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 814,000,000
- Address
- Unit 2303-07, 23/F, Tower 1, Millennium, KOWLOON
- Web
- https://www.jbmhealthcare.com.hk/
- Phone
- +852 null22672178
- Auditors
- KPMG
Upcoming Events for 2161
Similar to 2161
3D Medicines
Stock Exchange of Hong Kong Limited
3SBio
Stock Exchange of Hong Kong Limited
AIM Vaccine Co
Stock Exchange of Hong Kong Limited
Ascletis Pharma
Stock Exchange of Hong Kong Limited
Asymchem Laboratories Tianjin Co
Stock Exchange of Hong Kong Limited
FAQ
What is the Jbm (Healthcare) share price?
As of Today at 21:26 UTC, shares in Jbm (Healthcare) are trading at HK$2.26. This share price information is delayed by 15 minutes.
How has the Jbm (Healthcare) share price performed this year?
Shares in Jbm (Healthcare) last closed at HK$2.26 and the price had moved by +156.82% over the past 365 days. In terms of relative price strength the Jbm (Healthcare) share price has outperformed the FTSE Developed Asia Pacific Index by +159.75% over the past year.
What are the analyst and broker recommendations for Jbm (Healthcare)?
The overall consensus recommendation for Jbm (Healthcare) is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Jbm (Healthcare) dividend yield?
The Jbm (Healthcare) dividend yield is 4.23% based on the trailing twelve month period.
Does Jbm (Healthcare) pay a dividend?
Last year, Jbm (Healthcare) paid a total dividend of HK$0.10, and it currently has a trailing dividend yield of 4.23%. We do not have any data on when Jbm (Healthcare) is to next pay dividends.
When does Jbm (Healthcare) next pay dividends?
We do not have data on when Jbm (Healthcare) is to next pay dividends. The historic dividend yield on Jbm (Healthcare) shares is currently 4.23%.
How do I buy Jbm (Healthcare) shares?
To buy shares in Jbm (Healthcare) you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Jbm (Healthcare)?
As of the previous close price of HK$2.26, shares in Jbm (Healthcare) had a market capitalisation of HK$1.80bn.
Where are Jbm (Healthcare) shares listed?
Here are the trading details for Jbm (Healthcare):
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 2161
What kind of share is Jbm (Healthcare)?
Based on an overall assessment of its quality, value and momentum Jbm (Healthcare) is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Jbm (Healthcare) share price forecast for 2025?
The analyst consensus target price for shares in Jbm (Healthcare) is HK$2.47. That is 9.5% above the last closing price of HK$2.26.
Analysts covering Jbm (Healthcare) currently have a consensus Earnings Per Share (EPS) forecast of HK$0.20 for the next financial year.
Find out moreWhat is the trend in the Jbm (Healthcare) share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Jbm (Healthcare). Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +139.48%.
As of the last closing price of HK$2.26, shares in Jbm (Healthcare) were trading +57.72% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Jbm (Healthcare) PE Ratio?
The Jbm (Healthcare) PE ratio based on its reported earnings over the past 12 months is 9.7. The shares last closed at HK$2.26.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Jbm (Healthcare)?
Jbm (Healthcare)'s management team is headed by:
- Kwong Yip Sum - NEC
- Yat Wai Wong - CEO
- Man Yee Au - COO
- Ka Kin Wong - VPR
- Lin Wang - DGM
- Ka Wing Chu - EDR
- Kau Lap Lam - OTH
- Hoi Ki Leung - OTH
- Chui Yee Lo - OTH
- Kwok Chun Yeung - NED
- Chun Leung Yim - NED
- Kam Chiu Chan - NID
- Shut Lee Lau - NID
- Ting Lung Luk - NID